ArticleTherapeutic advances in endocrinology and metabolism2026
Evaluation of electronic order set implementation in patients with diabetic ketoacidosis: a retrospective cohort study.
Article in Therapeutic advances in endocrinology and metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes requiring timely insulin administration and dynamic fluid/electrolyte management. Objectives: The aim of this study is to assess the effectiveness of an electronic order set (PowerPlan) on time to DKA resolution compared to individual order prescribing. Design: Retrospective cohort study. Methods: This study included patients (⩾14 years old) with DKA, identified via electronic medical records, and matched to pre- and post-PowerPlan groups. The primary outcome was time to DKA resolution. Secondary outcomes included hospital length of stay, appropriateness of initial intravenous fluids, and insulin infusion. Safety outcomes included the number of hypoglycemia, hyperkalemia, and hypokalemia events until DKA resolution. Results: Of 226 matched patients (113 per group), baseline characteristics were comparable. The post-implementation group achieved faster DKA resolution (median 10.6 vs 12.6 h; Conclusion: Implementation of the DKA PowerPlan significantly shortened time to resolution and reduced hospital stay without compromising safety. These findings support standardized electronic order sets to enhance efficiency and quality of DKA management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.